Literature DB >> 6428900

Effects of plasma infusion on plasma lipids, apoproteins and plasma enzyme activities in familial lecithin: cholesterol acyltransferase deficiency.

N Murayama, Y Asano, K Kato, Y Sakamoto, S Hosoda, N Yamada, T Kodama, T Murase, Y Akanuma.   

Abstract

The siblings presented here are the third family found in Japan with familial LCAT deficiency. Their post-heparin plasma lipoprotein lipase and hepatic triglyceride lipase activities were measured selectively by an immunochemical method. Plasma triglyceride levels were elevated, and post-heparin plasma lipoprotein lipase was decreased only in a patient with nephropathy, while hepatic triglyceride lipase activities were within reference limits in both patients. The plasma concentrations of apo A-I, apo A-II, and apo B were reduced in both patients. On the other hand, the plasma concentration of apo E was markedly increased. Enzyme replacement therapy by plasma transfusion in the propositus resulted in marked improvement of deranged compositions of triglyceride-rich lipoproteins. Also, improvement of the plasma apo E concentration was demonstrated, while the improvement of post-heparin lipase did not occur. These results suggest that LCAT may play an important physiological role in triglyceride metabolism as well as in cholesterol metabolism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6428900     DOI: 10.1111/j.1365-2362.1984.tb02100.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  7 in total

1.  Effect of recombinant human lecithin cholesterol acyltransferase infusion on lipoprotein metabolism in mice.

Authors:  Xavier Rousset; Boris Vaisman; Bruce Auerbach; Brian R Krause; Reyn Homan; John Stonik; Gyorgy Csako; Robert Shamburek; Alan T Remaley
Journal:  J Pharmacol Exp Ther       Date:  2010-07-06       Impact factor: 4.030

Review 2.  Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor?

Authors:  Xavier Rousset; Robert Shamburek; Boris Vaisman; Marcelo Amar; Alan T Remaley
Journal:  Curr Atheroscler Rep       Date:  2011-06       Impact factor: 5.113

Review 3.  Lecithin: cholesterol acyltransferase--from biochemistry to role in cardiovascular disease.

Authors:  Xavier Rousset; Boris Vaisman; Marcelo Amar; Amar A Sethi; Alan T Remaley
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-04       Impact factor: 3.243

Review 4.  Current Status of Familial LCAT Deficiency in Japan.

Authors:  Masayuki Kuroda; Hideaki Bujo; Koutaro Yokote; Takeyoshi Murano; Takashi Yamaguchi; Masatsune Ogura; Katsunori Ikewaki; Masahiro Koseki; Yasuo Takeuchi; Atsuko Nakatsuka; Mika Hori; Kota Matsuki; Takashi Miida; Shinji Yokoyama; Jun Wada; Mariko Harada-Shiba
Journal:  J Atheroscler Thromb       Date:  2021-04-18       Impact factor: 4.928

5.  An unusual presentation of LCAT deficiency as nephrotic syndrome with normal serum HDL-C level.

Authors:  Manish R Balwani; Vijaykumar A Ghodela; Vivek B Kute; Pankaj R Shah; Himanshu V Patel; Dinesh N Gera; Aruna Vanikar; Hargovind L Trivedi
Journal:  J Nephropharmacol       Date:  2016-01-05

Review 6.  Proatherogenic Sialidases and Desialylated Lipoproteins: 35 Years of Research and Current State from Bench to Bedside.

Authors:  Alexandre Mezentsev; Evgeny Bezsonov; Dmitry Kashirskikh; Mirza S Baig; Ali H Eid; Alexander Orekhov
Journal:  Biomedicines       Date:  2021-05-25

Review 7.  A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency.

Authors:  Cecilia Vitali; Archna Bajaj; Christina Nguyen; Jill Schnall; Jinbo Chen; Kostas Stylianou; Daniel J Rader; Marina Cuchel
Journal:  J Lipid Res       Date:  2022-01-20       Impact factor: 5.922

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.